Immunophenotyping of hematopoietic neoplasms.
Advances in the staging and treatment of hematopoietic neoplasms have necessitated a high degree of accuracy in the diagnosis and classification of these tumors. A greater degree of diagnostic precision has resulted from recent advances in immunophenotyping and genotyping of hematopoietic neoplasms. This review discusses several new immunohistochemical reagents, many of which are derived from results of molecular studies.
Chu
P G
PG
Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Chang
K L
KL
Arber
D A
DA
Weiss
L M
LM
D000906:Antibodies / Q000276:immunology; D000941:Antigens / Q000032:analysis / Q000276:immunology; D014408:Biomarkers, Tumor / Q000032:analysis / Q000276:immunology; D001855:Bone Marrow Diseases / Q000175:diagnosis / Q000276:immunology; D005629:Frozen Sections; D019337:Hematologic Neoplasms / Q000175:diagnosis* / Q000276:immunology*; D006801:Humans; D016130:Immunophenotyping / Q000379:methods*; D008223:Lymphoma / Q000175:diagnosis / Q000276:immunology; D010232:Paraffin
D000906:Antibodies; D000941:Antigens; D014408:Biomarkers, Tumor; D010232:Paraffin